000			01554 a2200433 4500
005			20250517041754.0
264		0	_c20160524
008			201605s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.4524 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Shuai
245	0	0	_aAre VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer? _h[electronic resource]
260			_bOncotarget _cJul 2015
300			_a18206-23 p. _bdigital
500			_aPublication Type: Journal Article; Meta-Analysis; Review
650	0	4	_aAngiogenesis Inhibitors _xadverse effects
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aChi-Square Distribution
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aOdds Ratio
650	0	4	_aProtein Kinase Inhibitors _xadverse effects
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors
650	0	4	_aRisk Factors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aYang, Zhe
700	1		_aWang, Zhou
773	0		_tOncotarget _gvol. 6 _gno. 20 _gp. 18206-23
856	4	0	_uhttps://doi.org/10.18632/oncotarget.4524 _zAvailable from publisher's website
999			_c25056240 _d25056240